FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Seunghee Kim-Schulze

Research Profile

Chemicals & Drugs

Anatomy

Living Beings

Vaccinia virus

Disorders

Co-author Network

Publications

TOP 3
Howard Kaufman; Dae Won Kim; Gail DeRaffele; Josephine Mitcham; Rob S Coffin; Seunghee Kim-Schulze
Local and distant immunity induced by intralesional vaccination with an oncolytic herpes virus encoding GM-CSF in patients with stage IIIc and IV melanoma.
Hong Sung Kim; Seunghee Kim-Schulze; Dae Won Kim; Howard Kaufman
Host lymphodepletion enhances the therapeutic activity of an oncolytic vaccinia virus expressing 4-1BB ligand.
Marianna Sabatino; Seunghee Kim-Schulze; Monica C Panelli; David Stroncek; Ena Wang; Bret Taback; Dae Won Kim; Gail DeRaffele; Zoltan Pos; Francesco M Marincola; Howard Kaufman
Serum vascular endothelial growth factor and fibronectin predict clinical response to high-dose interleukin-2 therapy.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Seunghee Kim-Schulze (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2010: Howard Kaufman; Dae Won Kim; Gail DeRaffele; Josephine Mitcham; Rob S Coffin; Seunghee Kim-Schulze
Local and distant immunity induced by intralesional vaccination with an oncolytic herpes virus encoding GM-CSF in patients with stage IIIc and IV melanoma.
Annals of surgical oncology 2010;17(3):718-30.
2009: Hong Sung Kim; Seunghee Kim-Schulze; Dae Won Kim; Howard Kaufman
Host lymphodepletion enhances the therapeutic activity of an oncolytic vaccinia virus expressing 4-1BB ligand.
Cancer research 2009;69(21):8516-25.
2009: Marianna Sabatino; Seunghee Kim-Schulze; Monica C Panelli; David Stroncek; Ena Wang; Bret Taback; Dae Won Kim; Gail DeRaffele; Zoltan Pos; Francesco M Marincola; Howard Kaufman
Serum vascular endothelial growth factor and fibronectin predict clinical response to high-dose interleukin-2 therapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(16):2645-52.
2009: Seunghee Kim-Schulze; Hong Sung Kim; Qing Fan; Dae Won Kim; Howard Kaufman
Local IL-21 promotes the therapeutic activity of effector T cells by decreasing regulatory T cells within the tumor microenvironment.
Molecular therapy : the journal of the American Society of Gene Therapy 2009;17(2):380-8.
2009: Seunghee Kim-Schulze; Howard Kaufman
Gene therapy for antitumor vaccination.
Methods in molecular biology (Clifton, N.J.) 2009;542():515-27.
2009: Howard Kaufman; Bret Taback; william sherman; Dae Won Kim; William H Shingler; Dorota Moroziewicz; Gail DeRaffele; Josephine Mitcham; Miles W Carroll; Richard Harrop; Stuart Naylor; Seunghee Kim-Schulze
Phase II trial of Modified Vaccinia Ankara (MVA) virus expressing 5T4 and high dose Interleukin-2 (IL-2) in patients with metastatic renal cell carcinoma.
Journal of translational medicine 2009;7():2.
2008: Seunghee Kim-Schulze; Hong Sung Kim; Alberto Wainstein; Dae Won Kim; Wein Cui Yang; Dorota Moroziewicz; Phyllus Y Mong; Michal Bereta; Bret Taback; Qin Wang; Howard Kaufman
Intrarectal vaccination with recombinant vaccinia virus expressing carcinoembronic antigen induces mucosal and systemic immunity and prevents progression of colorectal cancer.
Journal of immunology (Baltimore, Md. : 1950) 2008;181(11):8112-9.
2008: Howard Kaufman; Heinz-Josef Lenz; John Marshall; Deepti Singh; Chris Garett; Christine Cripps; Malcolm Moore; Margaret von Mehren; Richard Dalfen; William J Heim; Robert M Conry; Walter J Urba; Al B Benson; Maria Yu; Judy Caterini; Seunghee Kim-Schulze; Mark DeBenedette; Danielle Salha; Thorsten Vogel; Ileana Elias; Neil L Berinstein
Combination chemotherapy and ALVAC-CEA/B7.1 vaccine in patients with metastatic colorectal cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(15):4843-9.
2007: Seunghee Kim-Schulze; Bret Taback; Howard Kaufman
Cytokine therapy for cancer.
Surgical oncology clinics of North America 2007;16(4):793-818, viii.
2007: Howard Kaufman; Seunghee Kim-Schulze; Kelledy Manson; Gail DeRaffele; Josephine Mitcham; Kang Seok Seo; Dae Won Kim; John Marshall
Poxvirus-based vaccine therapy for patients with advanced pancreatic cancer.
Journal of translational medicine 2007;5():60.
2006: Christian A Petrulio; Seunghee Kim-Schulze; Howard Kaufman
The tumour microenvironment and implications for cancer immunotherapy.
Expert opinion on biological therapy 2006;6(7):671-84.
2006: Chie Kudo-Saito; James W Hodge; Heesun Kwak; Seunghee Kim-Schulze; Jeffrey Schlom; Howard Kaufman
4-1BB ligand enhances tumor-specific immunity of poxvirus vaccines.
Vaccine 2006;24(23):4975-86.
2006: Giovanni C Cesana; Gail DeRaffele; Seth Cohen; Dorota Moroziewicz; Josephine Mitcham; John Stoutenburg; Kenneth Cheung; Charles Hesdorffer; Seunghee Kim-Schulze; Howard Kaufman
Characterization of CD4+CD25+ regulatory T cells in patients treated with high-dose interleukin-2 for metastatic melanoma or renal cell carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(7):1169-77.
2006: Seunghee Kim-Schulze; Luigi Scotto; George Vlad; Flavia Piazza; Hana Lin; Zhuoru Liu; Raffaello Cortesini; Nicole Suciu-Foca
Recombinant Ig-like transcript 3-Fc modulates T cell responses via induction of Th anergy and differentiation of CD8+ T suppressor cells.
Journal of immunology (Baltimore, Md. : 1950) 2006;176(5):2790-8.
2006: Seunghee Kim-Schulze; T Seki; George Vlad; Luigi Scotto; Jianshe Fan; Paolo C Colombo; Jiawang Liu; Raffaello Cortesini; Nicole Suciu-Foca
Regulation of ILT3 gene expression by processing of precursor transcripts in human endothelial cells.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2006;6(1):76-82.
2005: Adriana I Colovai; Elena R Vasilescu; Aurica Foca-Rodi; Seunghee Kim-Schulze; Najeeb Hussaini; Vivette D D'Agati; Glen S Markowitz; Chuan Wang; David J Cohen; Mark A Hardy; Nicole Suciu-Foca
Acute and hyperacute humoral rejection in kidney allograft recipients treated with anti-human thymocyte antibodies.
Human immunology 2005;66(5):501-12.
2005: Nicole Suciu-Foca; John Manavalan; Luigi Scotto; Seunghee Kim-Schulze; Sara Galluzzo; Afzal J Naiyer; Jianshe Fan; George Vlad; Raffaello Cortesini
Molecular characterization of allospecific T suppressor and tolerogenic dendritic cells: review.
International immunopharmacology 2005;5(1):7-11.
2004: Jiawang Liu; Zhuoru Liu; Piotr Witkowski; George Vlad; John Manavalan; Luigi Scotto; Seunghee Kim-Schulze; Raffaello Cortesini; Mark A Hardy; Nicole Suciu-Foca
Rat CD8+ FOXP3+ T suppressor cells mediate tolerance to allogeneic heart transplants, inducing PIR-B in APC and rendering the graft invulnerable to rejection.
Transplant immunology 2004;13(4):239-47.
2004: Luigi Scotto; Afzal J Naiyer; Sara Galluzzo; Paola Rossi; John Manavalan; Seunghee Kim-Schulze; Jianshe Fang; Riccardo Dalla Favera; Raffaello Cortesini; Nicole Suciu-Foca
Overlap between molecular markers expressed by naturally occurring CD4+CD25+ regulatory T cells and antigen specific CD4+CD25+ and CD8+CD28- T suppressor cells.
Human immunology 2004;65(11):1297-306.
2004: Nicole Suciu-Foca Cortesini; Adriana I Colovai; John Manavalan; Sara Galluzzo; Afzal J Naiyer; Jiawang Liu; George Vlad; Seunghee Kim-Schulze; Luigi Scotto; Jianshe Fan; Raffaello Cortesini
Role of regulatory and suppressor T-cells in the induction of ILT3+ ILT4+ tolerogenic endothelial cells in organ allografts.
Transplant immunology 2004;13(2):73-82.
2004: John Manavalan; Seunghee Kim-Schulze; Luigi Scotto; Afzal J Naiyer; George Vlad; Paolo C Colombo; Charles C Marboe; Donna Mancini; Raffaello Cortesini; Nicole Suciu-Foca
Alloantigen specific CD8+CD28- FOXP3+ T suppressor cells induce ILT3+ ILT4+ tolerogenic endothelial cells, inhibiting alloreactivity.
International immunology 2004;16(8):1055-68.